BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1712 related articles for article (PubMed ID: 24111495)

  • 1. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura-what is new?
    Shah N; Sarode R
    J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P; Veyradier A
    Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
    Chapman K; Seldon M; Richards R
    Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
    Vesely SK; George JN; Lämmle B; Studt JD; Alberio L; El-Harake MA; Raskob GE
    Blood; 2003 Jul; 102(1):60-8. PubMed ID: 12637323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case series of atypical presentations of thrombotic thrombocytopenic purpura.
    Imanirad I; Rajasekhar A; Zumberg M
    J Clin Apher; 2012; 27(4):221-6. PubMed ID: 22467376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura: from diagnosis to therapy.
    Mariotte E; Veyradier A
    Curr Opin Crit Care; 2015 Dec; 21(6):593-601. PubMed ID: 26418759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.
    Browning S; Bahar B; Lee AI; Gorshein E
    Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.